Comparative Analyses of SUV420H1 Isoforms and SUV420H2 Reveal Differences in Their Cellular Localization and Effects on Myogenic Differentiation

被引:31
|
作者
Tsang, Leanna W. K. [1 ]
Hu, Ninghe [1 ]
Underhill, D. Alan [1 ,2 ]
机构
[1] Univ Alberta, Sch Human Dev, Dept Med Genet, Edmonton, AB, Canada
[2] Univ Alberta, Dept Oncol, Sch Canc Engn & Imaging Sci, Fac Med & Dent, Edmonton, AB, Canada
来源
PLOS ONE | 2010年 / 5卷 / 12期
基金
加拿大健康研究院;
关键词
HISTONE METHYLTRANSFERASE ACTIVITY; H4K20; TRIMETHYLATION; GENE-EXPRESSION; H4-LYSINE; 20; METHYLATION; LYSINE-20; H4; CHROMATIN; MONOMETHYLATION; PR-SET7;
D O I
10.1371/journal.pone.0014447
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Methylation of histone H4 on lysine 20 plays critical roles in chromatin structure and function via mono( H4K20me1), di-(H4K20me2), and trimethyl (H4K20me3) derivatives. In previous analyses of histone methylation dynamics in mid-gestation mouse embryos, we documented marked changes in H4K20 methylation during cell differentiation. These changes were particularly robust during myogenesis, both in vivo and in cell culture, where we observed a transition from H4K20me1 to H4K20me3. To assess the significance of this change, we used a gain-of-function strategy involving the lysine methyltransferases SUV420H1 and SUV420H2, which catalyze H4K20me2 and H4K20me3. At the same time, we characterized a second isoform of SUV420H1 (designated SUV420H1_i2) and compared the activity of all three SUV420H proteins with regard to localization and H4K20 methylation. Principal Findings: Immunofluorescence revealed that exogenous SUV420H1_i2 was distributed throughout the cell, while a substantial portion of SUV420H1_i1 and SUV420H2 displayed the expected association with constitutive heterochromatin. Moreover, SUV420H1_i2 distribution was unaffected by co-expression of heterochromatin protein-1 alpha, which increased the targeting of SUV420H1_i1 and SUV420H2 to regions of pericentromeric heterochromatin. Consistent with their distributions, SUV420H1_i2 caused an increase in H4K20me3 levels throughout the nucleus, whereas SUV420H1_i1 and SUV420H2 facilitated an increase in pericentric H4K20me3. Striking differences continued when the SUV420H proteins were tested in the C2C12 myogenic model system. Specifically, although SUV420H1_i2 induced precocious appearance of the differentiation marker Myogenin in the presence of mitogens, only SUV420H2 maintained a Myogenin-enriched population over the course of differentiation. Paradoxically, SUV420H1_i1 could not be expressed in C2C12 cells, which suggests it is under post-transcriptional or post-translational control. Conclusions: These data indicate that SUV420H proteins differ substantially in their localization and activity. Importantly, SUV420H2 can induce a transition from H4K20me1 to H4K20me3 in regions of constitutive heterochromatin that is sufficient to enhance myogenic differentiation, suggesting it can act an as epigenetic 'switch' in this process.
引用
收藏
页数:12
相关论文
共 33 条
  • [31] Histone H3 Methyltransferase Suv39h1 Prevents Myogenic Terminal Differentiation by Repressing MEF2 Activity in Muscle Cells
    Jin, Wei
    Shang, Yangyang
    Peng, Jian
    Jiang, Siwen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (12):
  • [32] miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2
    Wu, You
    Shi, Wanyue
    Tang, Tingting
    Wang, Yidong
    Yin, Xin
    Chen, Yanlin
    Zhang, Yanfeng
    Xing, Yun
    Shen, Yumeng
    Xia, Tiansong
    Guo, Changying
    Pan, Yi
    Jin, Liang
    CELL DEATH & DISEASE, 2019, 10 (3)
  • [33] miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via downregulating histone H4K20 trimethylation through directly targeting SUV420H2 (vol 10, 176, 2019)
    Wu, You
    Shi, Wanyue
    Tang, Tingting
    Wang, Yidong
    Yin, Xin
    Chen, Yanlin
    Zhang, Yanfeng
    Xing, Yun
    Shen, Yumeng
    Xia, Tiansong
    Guo, Changying
    Pan, Yi
    Jin, Liang
    CELL DEATH & DISEASE, 2019, 10 (11)